The transition to first-in-man remains at a critical stage. Crucial regulatory, scientific and operational issues need to be confronted head on in order to avoid high costs and high profile product failures. Safety concerns continue to dominate and following recommendations from the ESG working group, the ABPI has revised its guidelines for phase I trials.
For delegates Health Network Communications would like to announce the forthcoming Exploratory Clinical Development World Americas that is taking place in Philadelphia, USA in September 2008.
This event follows the huge success of our European event in 2007 and the forthcoming European conference in May 2008, to which Health Network attracted a record number of early development scientists and decision makers to explore the challenges of Phase I trials.
The history
The event in September 2008 will build on this success within the US market. It will address the critical issues in achieving seamless first in man studies and will also provide advice on how to conduct effective studies that facilitate making the right decisions early on in clinical development.
Our speakers At Exploratory Clinical Development World Americas you can expect to see speakers from a wide range of countries from around the globe. There will be case study updates, and we will strive to introduce fresh strategy content as we continue to keep track of the latest developments.
This event will be attended by directors, heads and managers working in the pharmaceutical industry in the following departments:
Clinical Research
Clinical Pharmacology
Phase I Trials
Exploratory Development
Clinical Trials
Regulatory Affairs
PK/PD
Clinical Operations
The World’s most progressive organisations are already exploiting the full spectrum of Exploratory Clinical Development World Americas and saving time and money by doing so. No organisation in this field can consider moving forward without hearing from the experts at this event. Hear practical presentations and case study updates.
